GlassScriptPhysician profile
Daniel Srikureja
NPI 1235455270
$25,332.43
in general payments reported to CMS, 2019-2025
10 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $532 · 2021: $6,332 · 2022: $1,435 · 2023: $2,606 · 2024: $2,164 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Food and Beverage: $2,335 · Travel and Lodging: $2,184 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Food and Beverage | $2,335.42 |
| Travel and Lodging | $2,183.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,374.57 | 2019-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $1,774.68 | 2023-2024 | Advantagerib |
| W. L. Gore & Associates, INC. | $1,261.21 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Stryker Corporation | $399.04 | 2019-2021 | |
| Davol INC. | $185.56 | 2022-2023 | Ventralight St |
| Ethicon US, LLC | $145.63 | 2021-2025 | Echelon Circular |
| Conmed Corporation | $108.70 | 2023 | Airseal |
| Cerus Corporation | $48.16 | 2023-2024 | Intercept Blood System For Platelets |
| Haemonetics Corporation | $21.12 | 2024 | Teg6s Hemostasis System |
| Solventum Corporation | $13.76 | 2024 | V.A.C. Veraflo, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Srikureja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.